[go: up one dir, main page]

ATE403679T1 - Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum - Google Patents

Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum

Info

Publication number
ATE403679T1
ATE403679T1 AT03723513T AT03723513T ATE403679T1 AT E403679 T1 ATE403679 T1 AT E403679T1 AT 03723513 T AT03723513 T AT 03723513T AT 03723513 T AT03723513 T AT 03723513T AT E403679 T1 ATE403679 T1 AT E403679T1
Authority
AT
Austria
Prior art keywords
fibrinogen
fibrin
properties
lmw
hmw
Prior art date
Application number
AT03723513T
Other languages
English (en)
Inventor
Maat Monica De
Pieter Koolwijk
Original Assignee
Tno
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tno filed Critical Tno
Application granted granted Critical
Publication of ATE403679T1 publication Critical patent/ATE403679T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/046—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03723513T 2002-04-18 2003-04-07 Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum ATE403679T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1020426A NL1020426C2 (nl) 2002-04-18 2002-04-18 Modificatie van de eigenschappen van een fibrinematrix met betrekking tot groei en ingroei van cellen.

Publications (1)

Publication Number Publication Date
ATE403679T1 true ATE403679T1 (de) 2008-08-15

Family

ID=29244993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03723513T ATE403679T1 (de) 2002-04-18 2003-04-07 Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum

Country Status (10)

Country Link
US (2) US7867519B2 (de)
EP (1) EP1495051B1 (de)
JP (3) JP5083928B2 (de)
AT (1) ATE403679T1 (de)
AU (1) AU2003230455A1 (de)
CA (1) CA2482893C (de)
DE (1) DE60322687D1 (de)
DK (1) DK1495051T3 (de)
NL (1) NL1020426C2 (de)
WO (1) WO2003087160A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514474C (en) 2003-01-30 2014-05-06 Avner Yayon Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
WO2008081463A2 (en) 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
CA2717725A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
WO2010004004A1 (en) 2008-07-09 2010-01-14 Profibrix Bv Recombinant fibrinogen
CA2785594C (en) * 2010-01-08 2018-04-17 Profibrix Bv Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
NZ600812A (en) * 2010-01-08 2014-08-29 Profibrix Bv Dry powder fibrin sealant
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2017027378A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
JP7498925B2 (ja) 2020-08-31 2024-06-13 丸一株式会社 排水栓装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE212554T1 (de) * 1990-11-27 2002-02-15 American Nat Red Cross Gewebeabdeckung und wachstumsfaktor enthaltende verbindungen zur förderung beschleunigter wundheilung
WO1995029686A1 (en) * 1994-05-02 1995-11-09 E.R. Squibb & Sons, Inc. Recombinant fibrin chains, fibrin and fibrin-homologs
AU697045B2 (en) * 1995-01-16 1998-09-24 Baxter International Inc. Self-supporting sheet-like material of cross-linked fibrin for preventing post- operative adhesions
US6037457A (en) * 1997-01-31 2000-03-14 The University Of North Carolina At Chapel Hill Method for recombinant fibrinogen production
WO1998055140A1 (en) * 1997-06-05 1998-12-10 Omrix Biopharmaceuticals S.A. Fibrinogen concentrate from human plasma
US6946140B1 (en) * 1999-02-09 2005-09-20 The Research Foundation Of State University Of New York Methods and compositions for enhancing fibroblast migration
WO2000062833A1 (en) * 1999-04-15 2000-10-26 The Research Foundation Of State University Of New York Cellular matrix system and use thereof
US6613325B1 (en) * 1999-06-01 2003-09-02 Bristol-Myers Squibb Company Prevention of post surgical adhesions using a fibrin monomer sealant

Also Published As

Publication number Publication date
AU2003230455A1 (en) 2003-10-27
JP2005538045A (ja) 2005-12-15
WO2003087160A1 (en) 2003-10-23
US20050181972A1 (en) 2005-08-18
US7867519B2 (en) 2011-01-11
JP5248547B2 (ja) 2013-07-31
NL1020426C2 (nl) 2003-10-21
EP1495051B1 (de) 2008-08-06
JP5083928B2 (ja) 2012-11-28
JP2010246543A (ja) 2010-11-04
EP1495051A1 (de) 2005-01-12
JP5395726B2 (ja) 2014-01-22
JP2010195805A (ja) 2010-09-09
CA2482893A1 (en) 2003-10-23
DE60322687D1 (de) 2008-09-18
CA2482893C (en) 2014-08-12
US20110071083A1 (en) 2011-03-24
DK1495051T3 (da) 2008-11-10

Similar Documents

Publication Publication Date Title
ATE403679T1 (de) Veränderung von eigenschaften einer fibrinmatrix in bezug auf das zellwachstum
ATE200630T1 (de) Verbundvliesstoff, enthaltend derivate von hyaluronsäure
DK0625056T3 (da) Kompositmembraner til reguleret regenerering af væv
DE3880318D1 (de) Polypeptide mit kollagen typ iv aktivitaet.
ATE262356T1 (de) Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement
DE69231421D1 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
DK1545565T3 (da) Sammensætninger, som indeholder mitotisk inaktiverede allogene fibroblaster og keratinocyter til anvendelse i regenerering af væv
FI964323A0 (fi) Kirurginen implantaatti, väline tai sen osa
GB2348426A (en) Enzyme-mediated modification of fibrin for tissue engineering
IS8909A (is) Rauðkornavaki til örvunar á innanþekju forverafrumum.
CA2097063A1 (en) Tissue sealant and growth factor containing compositions that promote accelerated wound healing
ATE525100T1 (de) Poröse matrix
BR0008787A (pt) Sistema à base de colágeno injetável para aplicação de células ou agentes terapêuticos
DE69913543T8 (de) Dermales Gerüst auf der Grundlage eines neutralisierten Chitosan-Schwammes oder eines neutralisierten gemischten Chitosan-Kollagen-Schwammes
DK1085917T3 (da) Biomaterialer indeholdende hyaluronsyrederivater i form af tredimensionale strukturer, som er frie for cellulære komponenter eller produkter deraf, til in vivo-regenerering af vævsceller
DE3877765D1 (de) Polypeptide mit einer laminin-wirksamkeit.
DE60107560D1 (de) Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe
DE60222543D1 (de) Fibrin enthaltende langgestreckte biopolymerstruktur
DE69820254D1 (de) Dermales hüllgewebe in der wundheilung
NO773189L (no) Kirurgisk sutur, samt fremgangsmaate ved lukking av saar i levende vev
DE69328100D1 (de) Biodegradierbare führungskanäle zur verwendung als chirurgische hilfsmittel in gewebewiederherstellung
ATE222501T1 (de) Tissue-faktor zur beeinflussung von gefässbildung
Pietramaggiori et al. Skin grafting and dermal substitute placement
UA36465A (uk) Спосіб ушивання глибоких і нешироких ран та голка для його здійснення

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1495051

Country of ref document: EP